The Indiana University Melvin and Bren Simon Comprehensive Cancer Center has named Antwione Haywood, PhD, its associate director of diversity, equity and inclusion (DEI). Haywood is the first person to hold the chief diversity officer position at the cancer center.
Two Indiana University Melvin and Bren Simon Comprehensive Cancer Center researchers are now part of a prestigious Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute.
Indiana University School of Medicine has appointed Kun Huang, PhD, as chair of the Department of Biostatistics and Health Data Science, effective October 1, 2021. Huang brings a tremendous amount of research, education and leadership experience to the role. He currently serves as vice chair for data science and professor with the department.
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center have identified how restoring a missing molecule in pancreatic fibrosis could help deliver treatments to cancer cells.
INDIANAPOLIS—A researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center received a five-year, $2.5 million grant from the National Cancer Institute to develop a novel therapy to treat lung cancer.
A new $11.2 million grant coordinated by the Indiana University School of Medicine from the National Institute on Aging (NIA) will support an international collaboration on multiethnic genomic analysis and advanced brain imaging and other biomarkers for early detection of Alzheimer’s disease.
Indiana University School of Medicine has recruited David M. Aronoff, MD, FIDSA, FAAM, for the role of chair of the Department of Medicine, effective January 3, 2022. A highly respected physician-scientist in the field of infectious diseases and reproductive health, and author of over 220 publications, Aronoff brings a wealth of knowledge and experience to the role of chair.